Turning Point Brands Announces Financial Performance for 2023: Sales down by 6% in Q4

Business by 2FIRSTS.ai
Feb.29.2024
Turning Point Brands Announces Financial Performance for 2023: Sales down by 6% in Q4
Turning Point Brands announces Q4 and full-year financial performance, with net sales down but profits up. optimism for 2024 growth.

American new tobacco product company Turning Point Brands announced its fourth quarter and full year financial performance ending on December 31, 2023.

 

In the fourth quarter of 2023, total combined net sales decreased by 6.1% to $97.1 million. Net sales for Zig-Zag products decreased by 2.9%, while net sales for Stoker's products increased by 18.6%. Net sales for innovative distribution solutions decreased by 43.7%. Gross profit increased by 1.9% to $50.5 million. Net income increased by $26.4 million to $10.1 million. Adjusted net income increased by 15.9% to $15.3 million. Adjusted EBITDA increased by 7.5% to $24.8 million.

 

TPB President and CEO Graham Purdy stated, "Our fourth quarter performance is at the high end of our expectations." "Aside from the impact of a discontinued product line, the Zig-Zag division has remained stable compared to last year and is expected to see growth in 2024. Stoker's had a strong performance this quarter, achieving the highest growth rate in four years, driven by double-digit growth in Stoker's MST. Over the past year, we have also achieved strong free cash flow, allowing us to build up a cash reserve to address the principal on our remaining convertible notes due in July. We are optimistic about the outlook for 2024 and expect steady growth in the Zig-Zag and Stoker's product businesses."

 

Our U.S. Zig-Zag and alternative channel businesses showed strong performance at the end of the year, achieving double-digit growth. With the reduction of trade inventory throughout the year, the zig-zag adjustment wave is now expected to recover growth with the help of long-term industry growth trends and internal growth initiatives.

 

"Stoker's has achieved strong market share growth in the MST and loose leaf categories, with its value proposition continuing to resonate with consumers," Perdi continued. "We are excited about the annual expansion of our FRe nicotine pouch products."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales
Philip Morris International Reports Q2 2025 Results: Revenue Reaches $10.14 Billion as Smoke-Free Products Rise to 41% of Total Sales
On July 22, Philip Morris International (PMI) reported Q2 2025 earnings with net revenue of $10.14 billion, up 7.1% year-over-year. Smoke-free product revenue reached $4.2 billion (41% of total), growing 14.5% organically. Heated tobacco shipments hit 38.8 billion units; e-vapor shipments more than doubled; nicotine pouch volume rose 43.3%. IQOS market share in Japan climbed to 31.7%. PMI raised its full-year EPS guidance to $7.24–$7.37.
Jul.22
Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
A new Australian study found flavored nicotine e-cigarettes are three times more effective than gum or lozenges for quitting smoking. The trial of 1,000 smokers on government support showed higher quit rates with vaping, but long-term health risks remain unclear.
Jul.17 by 2FIRSTS.ai
Legal Analysis: Why SKE Lost the “CRYSTAL BAR” Trademark Case and Key Takeaways
Legal Analysis: Why SKE Lost the “CRYSTAL BAR” Trademark Case and Key Takeaways
Attorney Liu Peiling analyzed SKE’s loss in the “CRYSTAL BAR” trademark case, highlighting the UK’s “first-to-file” principle and common pitfalls in Chinese firms’ overseas IP strategies, such as delayed registration and weak evidence. She urged Chinese brands to plan trademark filings early and improve evidence retention to avoid disputes and protect their rights.
Jul.07 by 2FIRSTS.ai
UK’s Boots Trials Vape Quitting Service at 10 Manchester Stores, Offers Nicotine Replacement Products
UK’s Boots Trials Vape Quitting Service at 10 Manchester Stores, Offers Nicotine Replacement Products
UK pharmacy and beauty chain Boots is piloting a vape quitting service at 10 stores in Manchester, offering a 12-week cessation program with product support. Surveys show over half of Manchester’s vapers intend to quit, and health bodies are urging the service to expand into comprehensive nicotine cessation support.
Jul.10 by 2FIRSTS.ai
New Law in New South Wales, Australia: Selling Illegal E-cigarettes May Lead to Up to 7 Years in Prison and Over One Million Dollars in Fines
New Law in New South Wales, Australia: Selling Illegal E-cigarettes May Lead to Up to 7 Years in Prison and Over One Million Dollars in Fines
The New South Wales (NSW) government in Australia plans to introduce the strictest nationwide legislation to crack down on the sale of illegal tobacco and e-cigarette products. Offenders face fines of up to AUD 1.5 million (approximately $990,000) and imprisonment for up to 7 years.
Jul.28 by 2FIRSTS.ai
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Non-Nicotine Smoking Cessation Drug Cytisinicline Submitted for FDA Review
Cytisinicline has been submitted for FDA approval and, if approved, would become the first non-nicotine smoking cessation drug in 20 years.
Jul.07 by 2FIRSTS.ai